Article Versions Notes

Monnin A, Vizeneux A, Nagot N, Eymard-Duvernay S, Meda N, Singata-Madliki M, Ndeezi G, Tumwine JK, Kankasa C, Goga A, et al. Longitudinal Follow-Up of Blood Telomere Length in HIV-Exposed Uninfected Children Having Received One Year of Lopinavir/Ritonavir or Lamivudine as Prophylaxis. Children. 2021; 8(9):796. https://doi.org/10.3390/children8090796

Monnin, Audrey, Amélie Vizeneux, Nicolas Nagot, Sabrina Eymard-Duvernay, Nicolas Meda, Mandisa Singata-Madliki, Grace Ndeezi, James Kashugyera Tumwine, Chipepo Kankasa, Ameena Goga, and et al. 2021. "Longitudinal Follow-Up of Blood Telomere Length in HIV-Exposed Uninfected Children Having Received One Year of Lopinavir/Ritonavir or Lamivudine as Prophylaxis" Children 8, no. 9: 796. https://doi.org/10.3390/children8090796

Monnin, A., Vizeneux, A., Nagot, N., Eymard-Duvernay, S., Meda, N., Singata-Madliki, M., Ndeezi, G., Tumwine, J. K., Kankasa, C., Goga, A., Tylleskär, T., Van de Perre, P., & Molès, J.-P. (2021). Longitudinal Follow-Up of Blood Telomere Length in HIV-Exposed Uninfected Children Having Received One Year of Lopinavir/Ritonavir or Lamivudine as Prophylaxis. Children, 8(9), 796. https://doi.org/10.3390/children8090796